肾脏疾病
肠道菌群
免疫学
疾病
生物
医学
内科学
病理
作者
Paulina Mertowska,Sebastian Mertowski,Julia Wojnicka,Izabela Korona‐Głowniak,Ewelina Grywalska,Anna Błażewicz,Wojciech Załuska
出处
期刊:Nutrients
[Multidisciplinary Digital Publishing Institute]
日期:2021-10-17
卷期号:13 (10): 3637-3637
被引量:58
摘要
Chronic kidney disease (CKD) is generally progressive and irreversible, structural or functional renal impairment for 3 or more months affecting multiple metabolic pathways. Recently, the composition, dynamics, and stability of a patient’s microbiota has been noted to play a significant role during disease onset or progression. Increasing urea concentration during CKD can lead to an acceleration of the process of kidney injury leading to alterations in the intestinal microbiota that can increase the production of gut-derived toxins and alter the intestinal epithelial barrier. A detailed analysis of the relationship between the role of intestinal microbiota and the development of inflammation within the symbiotic and dysbiotic intestinal microbiota showed significant changes in kidney dysfunction. Several recent studies have determined that dietary factors can significantly influence the activation of immune cells and their mediators. Moreover, dietary changes can profoundly affect the balance of gut microbiota. The aim of this review is to present the importance and factors influencing the differentiation of the human microbiota in the progression of kidney diseases, such as CKD, IgA nephropathy, idiopatic nephropathy, and diabetic kidney disease, with particular emphasis on the role of the immune system. Moreover, the effects of nutrients, bioactive compounds on the immune system in development of chronic kidney disease were reviewed.
科研通智能强力驱动
Strongly Powered by AbleSci AI